Page last updated: 2024-08-25

bromopyruvate and Glycogen Storage Disease Type II

bromopyruvate has been researched along with Glycogen Storage Disease Type II in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bassi, A; Beltrame, M; Blasevich, F; Bragato, C; Brix, A; Carra, S; Cotelli, F; Maggi, L; Mantegazza, R; Mora, M; Salerno, F	1

Other Studies

1 other study(ies) available for bromopyruvate and Glycogen Storage Disease Type II

Article	Year
Glycogen storage in a zebrafish Pompe disease model is reduced by 3-BrPA treatment. Biochimica et biophysica acta. Molecular basis of disease, 2020, 05-01, Volume: 1866, Issue:5 Topics: alpha-Glucosidases; Animals; Animals, Genetically Modified; Autophagy; Drug Evaluation, Preclinical; Gene Knockdown Techniques; Glycogen; Glycogen Storage Disease Type II; Glycolysis; Hexokinase; Humans; Lysosomes; Microscopy, Electron; Morpholinos; Motor Activity; Muscle, Skeletal; Pyruvates; Zebrafish; Zebrafish Proteins	2020

Article

Year

Glycogen storage in a zebrafish Pompe disease model is reduced by 3-BrPA treatment.

Biochimica et biophysica acta. Molecular basis of disease, 2020, 05-01, Volume: 1866, Issue:5

Topics: alpha-Glucosidases; Animals; Animals, Genetically Modified; Autophagy; Drug Evaluation, Preclinical; Gene Knockdown Techniques; Glycogen; Glycogen Storage Disease Type II; Glycolysis; Hexokinase; Humans; Lysosomes; Microscopy, Electron; Morpholinos; Motor Activity; Muscle, Skeletal; Pyruvates; Zebrafish; Zebrafish Proteins

2020